Cadia Rehab Renaissance: Drug Storage Failures - DE
The missing medication belonged to a resident identified as R123. On August 3, pharmacy records showed the facility received thirty morphine capsules for the patient. Two days later, a licensed practical nurse administered one capsule and documented twenty-nine remaining in the controlled substance log.
The next day brought the problem. The same LPN witnessed a registered nurse destroy twenty-four of the remaining morphine capsules. But the math didn't work. If twenty-nine capsules remained after giving one to the resident, destroying twenty-four should have left five capsules. Instead, the destruction paperwork showed zero remaining.
Five morphine capsules had vanished from the official count.
When inspectors arrived August 20 for a complaint investigation, the facility's chief nursing officer insisted no medication discrepancies existed. "The facility had not identified any medication reconciliation discrepancies regarding medications received from the pharmacy for R123," the CNO told investigators during a 1:38 PM interview.
Seven minutes later, inspectors confronted the LPN who had witnessed the drug destruction. She denied knowing about any deficit in the morphine count. When shown the actual medication records with her signature, she confirmed witnessing the destruction but said, "I don't remember there being an error."
The registered nurse who destroyed the capsules took a different approach when questioned. He confirmed his signature on the controlled drug log and acknowledged the five-capsule discrepancy. His explanation: "I think it's just a typo."
Neither nurse could account for what happened to the missing morphine. The clinical records contained no documentation explaining the deficit. The drug administration records offered no clarification for where five controlled substance capsules had gone.
Faced with the documented evidence, the chief nursing officer changed her story. In a second interview at 2:26 PM, she confirmed the discrepancy existed and called it "a clerical error."
Federal regulations require nursing homes to maintain accurate records of controlled substances, particularly opioids like morphine that carry high abuse potential. The medications must be tracked from delivery through administration or destruction, with any discrepancies investigated and documented.
Morphine capsules represent exactly the type of controlled substance that requires careful monitoring. The drug provides powerful pain relief for residents but also carries significant street value and addiction potential. Proper accounting helps prevent diversion by staff members and ensures residents receive prescribed medications.
The facility's response revealed systemic problems beyond the missing capsules. The chief nursing officer initially denied any discrepancies existed, suggesting inadequate oversight of controlled substance records. When presented with evidence, staff members offered conflicting explanations ranging from memory lapses to typographical errors.
No documentation existed to explain the discrepancy. The facility had not conducted an investigation into the missing morphine. Staff had not filed incident reports or taken corrective action. The deficit remained unexplained and unaddressed until federal inspectors discovered it during their review.
The inspection occurred following a complaint, though the report does not specify the nature of the original allegation that triggered the federal review. Inspectors completed their work August 25 and presented findings to the nursing home administrator, chief operating officer, and chief nursing officer during an exit conference.
The violation received a "minimal harm" classification, indicating inspectors determined the medication discrepancy posed limited immediate risk to residents. However, the finding demonstrates the facility's failure to maintain required pharmaceutical services and proper oversight of controlled substances.
Federal inspectors cited the facility under regulations requiring nursing homes to "provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist." The violation specifically addressed the facility's failure to ensure accurate medication reconciliation documentation for controlled drugs.
The five missing morphine capsules remain unaccounted for. Staff explanations of "typos" and "clerical errors" provide no insight into where the controlled substances went or why the facility's medication tracking systems failed to identify the discrepancy.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Cadia Rehabilitation Renaissance from 2025-08-25 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 21, 2026 · Our methodology
CADIA REHABILITATION RENAISSANCE in MILLSBORO, DE was cited for violations during a health inspection on August 25, 2025.
The missing medication belonged to a resident identified as R123.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.